Accuracy of Histology and Malignancy Grade Between Preoperative Biopsy and Surgical Specimens in Primary Retroperitoneal Sarcoma. A Study From the Prospective Retroperitoneal Sarcoma Registry (RESAR)
Alessandra Borghi(Fondazione IRCCS Istituto Nazionale dei Tumori), on behalf of the Transatlantic Australasian Retroperitoneal Sarcoma Working Group, Elena Di Blasi(Fondazione IRCCS Istituto Nazionale dei Tumori), Carol J. Swallow(University Health Network), Kenneth Cardona(Emory University), S. Bonvalot(Institut Curie), Ferdinando Cananzi(Humanitas University), Rebecca A. Gladdy(Princess Margaret Cancer Centre), Marko Novak(Peter MacCallum Cancer Centre), Rosalba Miceli(Fondazione IRCCS Istituto Nazionale dei Tumori), Valerie P. Grignol(Ohio State University Hospital), Chandrajit P. Raut(Dana-Farber Cancer Institute), D. Strauß(Royal Marsden Hospital), J. Wang(Dana-Farber Brigham Cancer Center), Markus Albertsmeier(LMU Klinikum), Max L. Almond(University Hospitals Birmingham NHS Foundation Trust), Gabriele Tinè(Fondazione IRCCS Istituto Nazionale dei Tumori), Michelle Wilkinson(Royal Marsden Hospital), D. Salvatore(Fondazione IRCCS Istituto Nazionale dei Tumori), Elisabetta Pennacchioli(European Institute of Oncology), Jacek Skoczylas(The Maria Sklodowska-Curie National Research Institute of Oncology), Piotr Rutkowski(The Maria Sklodowska-Curie National Research Institute of Oncology), Sergio Valeri(Campus Bio Medico University Hospital), Alessandro Gronchi(Fondazione IRCCS Istituto Nazionale dei Tumori), David E. Gyorki(Peter MacCallum Cancer Centre), Carolyn Nessim(Ottawa Hospital), Catherine Mitchell(The University of Melbourne), Samuel Ford(Genomics (United Kingdom)), Shintaro Iwata, M. Fiore(Fondazione IRCCS Istituto Nazionale dei Tumori), Andrew Hayes(Royal Marsden NHS Foundation Trust), Dimitri Tzanis(Université Paris Cité)
Cited by 2
Related Papers
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis
|The Lancet Oncology|2008|2k
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
|Journal of the National Comprehensive Cancer Network|2010|1.2k
NCCN Task Force Report: Management of Patients with Gastrointestinal Stromal Tumor (GIST)—Update of the NCCN Clinical Practice Guidelines
|Journal of the National Comprehensive Cancer Network|2007|636
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies
|Cancer Cell|2018|591